Literature DB >> 31335787

Pediatric Pain Assessment in the Emergency Department: Patient and Caregiver Agreement Using the Wong-Baker FACES and the Faces Pain Scale-Revised.

Simone L Lawson, Melanie M Hogg1, Charity G Moore2, William E Anderson3, Paul S Osipoff, Michael S Runyon1, Stacy L Reynolds1.   

Abstract

OBJECTIVE: This study aimed to assess the agreement between patients presenting to the pediatric emergency department (ED) with acute pain and their caregivers when using the Wong-Baker FACES (WBF) and Faces Pain Scale-Revised (FPS-R).
METHODS: This was a prospective, observational study examining patients 3 to 7.5 years old presenting to a pediatric ED with acute pain. Participants completed the WBF and FPS-R twice during their ED evaluation. Caregivers rated their child's pain using both the WBF and FPS-R at the same time points. Intraclass correlations (ICCs) were calculated between caregiver and child reports at each time point, and Bland-Altman plots were created.
RESULTS: Forty-six subjects were enrolled over 5 months. Mean age was 5.5 ± 1.2 years. Average initial child pain scores were 6.6 ± 2.8 (WBF) and 6.1 ± 3.3 (FPS-R), and repeat scores were 3.3 ± 3.4 (WBF) and 3.1 ± 3.3 (FPS-R). Average initial caregiver pain scores were 6.3 ± 2.4 (WBF) and 6.2 ± 2.3 (FPS-R), and repeat scores were 3.4 ± 2.0 (WBF) and 3.4 ± 2.1 (FPS-R). On initial assessment, ICCs between children and caregivers using the FPS-R and WBF were 0.33 and 0.22, respectively. On repeat assessment, the ICCs were 0.31 for FPS-R and 0.26 for WBF. Bland-Altman plots showed poor agreement but no systematic bias.
CONCLUSION: There was poor agreement between caregivers and children when using the WBF and FPS-R for assessment of acute pain in the ED. Caregiver report should not be used as a substitute for self-report of pain if possible.
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 31335787     DOI: 10.1097/PEC.0000000000001837

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  6 in total

1.  Fat transfer after parotidectomy: fat resorption rates, aesthetic and functional outcomes of en-bloc fat graft versus lipofilling technique.

Authors:  Merve Tunca; Nilda Sütay Süslü; Ayça A Karaosmanoğlu
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-20       Impact factor: 2.503

2.  Comparison of Endoscopic Radiofrequency Ablation and Argon Plasma Coagulation in Patients with Gastric Low-Grade Intraepithelial Neoplasia: A Large-Scale Retrospective Study.

Authors:  Nanjun Wang; Ningli Chai; Longsong Li; Huikai Li; Yaqi Zhai; Xiuxue Feng; Shengzhen Liu; Wengang Zhang; Enqiang Linghu
Journal:  Can J Gastroenterol Hepatol       Date:  2022-06-22

3.  Management of Oral Mucositis in Children With Malignant Solid Tumors.

Authors:  Giorgio Attinà; Alberto Romano; Palma Maurizi; Sara D'Amuri; Stefano Mastrangelo; Michele Antonio Capozza; Silvia Triarico; Antonio Ruggiero
Journal:  Front Oncol       Date:  2021-03-30       Impact factor: 6.244

4.  Antibiotic prescribing rate after optimal near-patient C-reactive protein testing in acutely ill children presenting to ambulatory care (ARON project): protocol for a cluster-randomized pragmatic trial.

Authors:  Jan Yvan Jos Verbakel; Tine De Burghgraeve; Ann Van den Bruel; Samuel Coenen; Sibyl Anthierens; Louise Joly; Annouschka Laenen; Jeroen Luyten; An De Sutter
Journal:  BMJ Open       Date:  2022-01-03       Impact factor: 2.692

5.  Consistency of pediatric pain ratings between dyads: an updated meta-analysis and metaregression.

Authors:  Huaqiong Zhou; Matthew A Albrecht; Pam A Roberts; Paul Porter; Phillip R Della
Journal:  Pain Rep       Date:  2022-09-22

6.  Clinical efficacy and prognostic risk factors of endoscopic radiofrequency ablation for gastric low-grade intraepithelial neoplasia.

Authors:  Nan-Jun Wang; Ning-Li Chai; Xiao-Wei Tang; Long-Song Li; Wen-Gang Zhang; En-Qiang Linghu
Journal:  World J Gastrointest Oncol       Date:  2022-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.